Raquel De Souza

Biocompatibility of injectable chitosan–phospholipid implant systems

Raquel De Souza, Payam Zahedi, Christine Allen et al. · Biomaterials · 2009 · 94 citations

Engineering, Biomedical Engineering, Implantable Device +2

Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer

Raquel De Souza, Payam Zahedi, Rose M. Badame et al. · Molecular Cancer Therapeutics · 2011 · 76 citations

Tumor Biology, Refractory Ovarian Cancer, Analyzed Genes +14

Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model

Vessela Vassileva, Justin Grant, Raquel De Souza et al. · Cancer Chemotherapy and Pharmacology · 2007 · 72 citations

Drug Targeting, Oncology, Polymer-drug Conjugate +9

Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)

Elena Geretti, Shannon C. Leonard, Nancy Dumont et al. · Molecular Cancer Therapeutics · 2015 · 58 citations

Companion Diagnostic ⁶⁴Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines

Helen Lee, Daniel F. Gaddy, Manuela Ventura et al. · Theranostics · 2018 · 57 citations · Full text